jRCT2031230586招募中不适用
An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects With Moderately to Severely Active Ulcerative Colitis (An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Subjects With Moderately to Severely Active Ulcerative Colitis)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 12age old over 至 17age old under（—）
- 性别
- All
入选标准
- •Inclusion criteria:
- •Have a diagnosis of ulcerative colitis (UC) that is moderately to severely active
- •Participants are permitted to be receiving a therapeutic dose of select UC therapies
排除标准
- •Exclusion criteria:
- •Severe extensive colitis
- •Diagnosis of Crohn's disease (CD) or indeterminate colitis or the presence or history of a fistula consistent with CD
- •Diagnosis of microscopic colitis, ischemic colitis, or infectious colitis
研究者
相似试验
招募中
不适用
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisColitis, UlcerativeNCT06398626Pfizer300
已完成
2 期
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisUlcerative ColitisNCT04607837Pfizer234
已完成
3 期
Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)Ulcerative ColitisNCT04706793Pfizer42
进行中（未招募）
不适用
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative ColitisColitis, UlcerativeNCT06294925Pfizer360
已完成
3 期
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisUlcerative ColitisNCT03945188Arena Pharmaceuticals433